U.S. stock futures were higher this morning, with the Dow futures gaining around 1,000 points on Monday.
Shares of Valneva SE (NASDAQ: VALN ) fell sharply in pre- market trading .
Pfizer (NYSE: PFE ) and Valneva disclosed topline results from Phase 3 VALOR clinical trial of investigational 6-Valent OspA-based Lyme disease vaccine candidate PF-0730740.
Valneva shares dipped 14% to $8.88 in pre-market trading.
Here are some other stocks moving lower in pre-market trading.
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here .
Posted In: News Pre-Market Outlook Markets Movers Trading Ideas #PreMarket Movers top losers